Interim estimates of vaccine effectiveness against influenza A(H1N1)pdm09 and A(H3N2) during a delayed influenza season, Canada, 2024/25.

• Tác giả: Nathalie Bastien, Sara Carazo, James A Dickinson, Ruimin Gao, Maan Hasso, Agatha N Jassem, Samantha E Kaweski, Richard G Mather, Isabelle Meunier, Romy Olsha, Suzana Sabaiduc, Lea Separovic, Danuta M Skowronski, Nathan Zelyas, Yuping Zhan
• Ngôn ngữ: eng
• Thông tin xuất bản: Sweden : Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin , 2025
• Bộ sưu tập: NCBI
• ID: 721325

Tóm tắt

The Canadian Sentinel Practitioner Surveillance Network (SPSN) reports interim 2024/25 vaccine effectiveness (VE) against acute respiratory illness due to laboratory-confirmed influenza during a delayed season of predominant A(H1N1)pdm09 and lower A(H3N2) co-circulation. Through mid-January, the risk of outpatient illness due to influenza A is reduced by about half among vaccinated vs unvaccinated individuals. Adjusted VE is 53% (95% CI: 36-65) against A(H1N1)pdm09, comprised of clades 5a.2a and 5a.2a.1, and 54% (95% CI: 29-70) against A(H3N2), virtually all clade 2a.3a.1.